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a  b  s  t  r  a  c  t
Systemic lupus erythematosus is an autoimmune disease that causes many  psychological
repercussions that have been studied through qualitative research. These are considered
relevant, since they reveal the amplitude experienced by patients. Given this importance,
this  study aims to map the qualitative production in this theme, derived from studies of
experiences of adult patients of both genders and that had used as a tool a semi-structured
interview and/or ﬁeld observations, and had made use of a sampling by a saturation cri-
terion to determine the number of participants in each study. The survey was conducted
in  Pubmed, Lilacs, Psycinfo e Cochrane databases, searching productions in English and
Portuguese idioms published between January 2005 and June 2012. The 19 revised papers
that  have dealt with patients in the acute phase of the disease showed themes that were
categorized into eight topics that contemplated the experienced process at various stages,
from the onset of the disease, extending through the knowledge of the diagnosis and the
understanding of the manifestations of the disease, drug treatment and general care, evo-
lution and prognosis. The collected papers also point to the difﬁculty of understanding, of
the  patients, on what consists the remission phase, revealing also that this is a clinical stageunderexplored by psychological studies.
© 2014 Elsevier Editora Ltda. All rights reserved. Department: Graduation Program in Medical Sciences/Mental Health Area, Universidade Estadual de Campinas, Campinas, SP, Brazil.
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Signiﬁcados  do  adoecer  para  pacientes  com  lúpus  eritematoso  sistêmico:
revisão  da  literatura
Palavras-chave:
Lúpus eritematoso sistêmico
Doenc¸a crônica
Adaptac¸ão psicológica
Pesquisa qualitativa
r  e  s  u  m  o
O lúpus eritematoso sistêmico é uma doenc¸a autoimune, que provoca diversas repercussões
psicológicas que têm sido estudadas por meio de pesquisas qualitativas. Essas são consid-
eradas relevantes, uma vez que reveladoras da amplitude vivenciada pelos pacientes. Face
a  essa relevância, este artigo buscou mapear a produc¸ão qualitativa na temática, oriunda de
estudos de vivências de pacientes adultos de ambos os gêneros e que tivessem usado como
instrumento a entrevista semiestruturada e/ou a observac¸ão de campo, além do critério de
amostragem por saturac¸ão na deﬁnic¸ão do número de participantes de cada estudo. O lev-
antamento foi feito nas bases de dados Pubmed, Lilacs, Psycinfo e Cochrane em busca de
produc¸ões em língua inglesa e portuguesa publicadas entre janeiro de 2005 e junho de 2012.
Os  19 artigos revisados que se ocuparam com pacientes em fase aguda da doenc¸a revelaram
temas categorizados em oito tópicos que contemplaram o processo vivenciado nas diversas
etapas, desde o desencadeamento da doenc¸a, passando pelo conhecimento do diagnóstico
pela e compreensão das manifestac¸ões da doenc¸a, até o tratamento medicamentoso e os
cuidados gerais, a evoluc¸ão e o prognóstico. Apontam também a difícil compreensão pelos
pacientes do que consiste a chamada fase de remissão, bem como nos revela que se trata
de  uma  fase clínica pouco explorada pelos estudos psicológicos.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.
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ystemic lupus erythematosus (SLE) is a disease with mul-
isystemic, chronic and inﬂammatory characteristics that
ffects mostly young women, in a ratio of nine women to one
an. Some authors attribute the onset of SLE to hormonal,
enetic, environmental and emotional factors.1,2
The scientiﬁc literature reports that often many  patients
nd up being accompanied by various medical specialties to
btain the correct diagnosis of the disease. Therefore, visits
o the doctor and the ever recurring symptoms are referred to
s factors that trigger feelings of insecurity, fear, anxiety and
tress.3 With the diagnosis, these sensations, settled or not,
ill be accompanied by other emotional states, now stemming
rom the treatment, which can accentuate this condition of
ersonal uncertainty.3 And these are experiences that qual-
tative trials aspire to study, in an attempt to understand
hem dynamically,4 as well as their interrelationship, to enable
oping with the whole treatment process. The goal of these
tudies is to contribute to more  assertive practices toward the
LE patient, assisting in his/her quality of care.
Given the relevance of these experiences and their little
xploitation in the scientiﬁc literature by means of qualita-
ive methodology, a bibliographic study of the subject was
eveloped, in order to map  the ﬁndings of this research model
argeted to the speciﬁc exploration of the meanings attributed
y patients with SLE.
Our aim is that the study will contribute to the under-
tanding of the conﬁguration of the emotional aspects that
ervade the experience of the treatment of SLE patients
lready exploited in this literature, and for the indication of
hose still not studied, in order to facilitate increasingly the
pproach by health professionals.Method
This review was based on a survey conducted in PUBMED,
LILACS, PSYCINFO and COCHRANE databases, from January
2005 to June 2012. In our search strategy, we  used the descrip-
tor “Lupus” combined with “Qualitative study”. The survey
resulted in 28 articles and of these, 19 met  the inclusion crite-
ria: publications in English and/or Portuguese language whose
studies had prioritized the experiences of adult patients of
both genders with SLE; and, with that in mind, that had used
semistructured interviews and/or ﬁeld observations as tools;
and that also have made use of the sampling criterion by sat-
uration to determine the number of participants.
The 19 articles were read in full and their ﬁndings were
analyzed, synthesized in an integrative way and grouped into
thematic categories.5 The preparation of these categories was
validated by investigators of the research group of the authors.
Results
With this bibliographic search, it was possible to conﬁrm the
growing interest, especially in the last seven years, for qualita-
tive studies on the sickening process in patients with SLE. This
is an editorial phenomenon, which is more  frequent from 2006
onwards. Prior to this period, in addition to being scarce, qual-
itative studies were devoted only to describe data on disease
symptoms, superposing with results from studies of quanti-
tative nature.The production analyzed, illustrated in Table 1, had dif-
ferent origins.6–24 Nine articles showed results of studies
conducted in Europe; four in Latin America; ﬁve in North
America and one in Asia. However, no study on experiences of
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Table 1 – Studies reviewed.
Author, country (year) Number of
patients in
each study
Results Main outcome
Gallop K, Nixon A, Swinburn P,
Sterling KL, Naegeli AN, Silk ME.
USA (2012)24
22 The study illustrates the great impact that the
symptoms cause in the patient’s life and the
potential of treatment in improving symptoms of
the disease.
Symptoms of the disease represent a large part in patients’ lives, which hinders
their day-to-day routine.
Mattson M, Möller B, Stamm T,
Gard G, Boström C. Sweden
(2011)21
19 It was found that SLE patients live among
uncertainties and the new opportunities provided
by the disease.
In  general, patients perceive the future as something uncertain, reporting that
their therapeutic contact with professionals helps in the treatment.
Waldon N, Brown S, Hewlett S,
Elliott B, McHugh N, McCabe C.
UK (2011)20
43 It was found that patients requested better
clariﬁcation in the post-diagnosis, in addition to
professional help.
In  general, participants stated that the support provided at the time of the
diagnostic information was insufﬁcient for their needs. They would like to
obtain more detailed information, by various means, provided that basically
backed up by professionals and available at any time of the patient’s trajectory.
The challenge for health professionals is to meet those needs in the most
beneﬁcial and effective way.
Kumar K, Gordon C, Barry R, Shaw
K, Horne R, Raza K. UK (2011)19
32 There was a request for further information about
drugs, longitudinal effects on the medication and
the individuality of each patient.
The inﬂuence of spiritual beliefs, concerns about side effects of medications,
religious beliefs about the incidence of disease and barriers to communication
with professionals regarding medication were found. In general, a negative way
to understand the importance of the medication can be perceived, which reveals
a need for educational intervention for medication adherence.
Berckerman NL. USA (2011)16 32 Relevant topics presented by patients: depression,
uncertainties about the disease, emotional fatigue
and physical and ﬁnancial hardships.
Emerging themes indicated high vulnerability to depressive states.
Manifestations of depression and anxiety are related to the management of the
uncertainty of the disease and to physical and emotional stress arising from the
experience of a chronic disease, as well as to the associated ﬁnancial aspects.
Such psychosocial aspects must be considered, from the screening to the
evaluation and planning of psychosocial treatment with this population.
McElbhone K, Abbott J, Gray J,
Williams A, Teh LS. UK (2010)15
30 Relevant themes were: prognosis and course of the
disease, body image, effects of treatment,
fatigue/pain, losses, speciﬁc care, cognition and
pregnancy
It  has been found through research that the majority of respondents perceive a
negative impact of SLE on their lives. The results presented in this study
identiﬁed important issues that can inform physicians about SLE patients’
outlook, enabling these professionals to undertake a new management with
respect to symptoms presented during the course of the disease
Pettersson S, Möller S,
Svenungsson E, Gunnarsson I,
Welin Henriksson E. Sweden
(2010)22
33 The report of the patients suggests that they can
control fatigue in their lives in various situations,
but in most cases, its occurrence severely limits the
daily life routine.
Health  professionals are encouraged to take a more active role to empower
people with SLE to meet their own balance, as a way to achieve a situation of
“being in control”.
Woods-Giscombe C L. USA (2010)18 48 Interests in the role of patients for
family/community preservation, as well as interests
of self-preservation.
The  results of this study indicate that the role of “Wonder Woman” is a
multidimensional phenomenon that encompasses features such as the
obligation to express strength, emotional suppression, demonstrate resistance
to vulnerability and dependency, determination to succeed and obligation to
help others. According to the women in this study, the role of “Wonder Woman”
involves socio-historical and personal contextual factors as well as themes of
survival and health status.
Robinson D, Aguilar D,
Schoenwetter M, Dubois R,
Russak S, Ramsey-Goldman R
et al. USA (2010)17
23 Patients reported their clinical doubts with respect
to pain, fatigue, withdrawal from work/school and
skin problems
In  general, SLE patients report symptoms that could signiﬁcantly affect their
daily life functioning. Treatments that substantially improve disease
manifestations will offer considerable beneﬁts for patients, medical treatment
and society.
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Table 1 – (Continued)
Author, country (year) Number of
patients in
each study
Results  Main outcome
Wittmann L, Sensky T. Meder L,
Michel B, Stoll T, Büchi S.
Switzerland (2009)11
12 Various forms of suffering alleviated with personal
reorganization when facing disease.
The  results were consistent with the concept of suffering as a psychological
process triggered and sustained by a threat of assessment, to the self or
“personality”. The results suggest that the various types of pain have to be
differentiated. Thus, recognizing personal growth, in response to the experience
of illness, is something that can reduce suffering.
Chambers SA, Raine R, Rahman A,
Isenberg D. UK (2009)13
220 The main reason suggested is the prolonged use of
medications, and their side effects.
The  reasons for patients to take (or not take) their drugs are largely related to
previous experiences with the disease. However, an improvement in
communication between doctors and patients may promote better adherence in
SLE patients.
Chambers S, Rine R, Rahman A,
Hagley K, De Ceulaer K, Isenberg
D. UK (2008)14
Noncompliance presented, as factors: cost and
difﬁculty of obtaining the medication, in addition to
side effects.
Conclusion: Socio-economic constraints and limited availability of drugs are
particularly important inﬂuences on the low adhesion in Jamaican SLE patients.
Religious beliefs and the use of herbal remedies do not seem to adversely affect
adherence, but are used when the medication can not be obtained.
Stamm TA, Bauernfeind B, Coenen
M, Feierl E, Mathis M, Stucki G,
et al. (2007)9
21 Overall, one can verify similarities between the
evaluation instruments and concepts stemmed
from patients: body, emotional factors,
environmental factors and personal factors.
Disease activity affects personal, social and interactional factors.
Araújo AD, Traverso-Yepez M.
Brazil (2007)23
8 Various forms of signiﬁcance were found in the
patients, changing with the progression of the
disease.
One needs an interdisciplinary approach to disease complexity, considering the
biopsychosocial dimension involved in the process, given the many meanings
attributed by respondents.
Costernbaden KH, Brome D,
Blanch D, Gall V, Karlson E, Liang
MH. USA (2007)10
40 Demographic factors were important in decisions on
prevention: study, personal beneﬁt, physical
impairment.
The purpose in determining what are the factors considered by patients with
SLE, while participating in trials of disease prevention, as well as if the disease
correlates with the study design, was answered concluding that similar factors
have different weights between participants and nonparticipants. Thus, the
results suggest that processes of health education, physician recruitment and
limiting the time required, may increase the recruitment of patients with SLE for
clinical prevention trials.
Meldson C. USA (2006)12 30 The main factor reported by patients was the
cognitive impairment after diagnosis.
The  complexity of a life with lupus is multidimensional, with regards to
overlapping issues. Life with lupus is identiﬁed as an life of uncertainty, with a
sense of identity change and the need to deal with the ﬁnancial burden arising
from the disease.
Mattje GD, Turato ER. Brazil (2006)8 5 Change in life routine for patients and the concepts
they construct about their illness were observed.
The  reactions of the patients included an attempt to rebuild their relationships
relying on their own strengths. Family and interpersonal conﬂicts of these
patients appear to be associated with the idea that family and friends do not
understand the nature of the disease.
Hale ED, Trehame GJ, et al. Reino
Unido (2006)6
10 Patients do not understand the precautions to be
taken. Further information from professionals on
the subject are suggested.
SLE  patients do not feel that are understood by health professionals or by the
people close to them. The support of trained volunteers and patients with SLE
can ensure a better information, because these are individuals with personal
experience. These services can improve communication and help minimize the
isolation of patients with SLE.
Goodmamn D, Morrissey S,
Graham D, Bossingham D.
Australia (2005)7
36 The results point to different forms of perception of
the disease, which are modiﬁed with the sickening
process.
Professionals should be prepared for the likelihood of changes in the
representations of the disease throughout its evolution, as this can be useful in
interventions in patients with SLE.
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sexuality, spirituality or even on interpersonal relationships of
patients with SLE, nor on the experiences of caregivers of SLE
patients were found. Also, no studies targeted to the experi-
ences of health professionals dedicated to these people were
published.
It is worth noting that the articles did not reveal how long
the SLE patients had the disease at the time of the interviews,
nor provided data to clarify whether these patients were in
stages of recurrence of the disease.
The studies analyzed allowed an integrative synthesis
of what has been understood in relation to the different
experiences of participants in the study of SLE patients, as
observed in studies that have examined the experiences of
these patients during the acute and active phase of the
disease. These ﬁndings are those that were grouped into
eight thematic categories, and which are described in this
article.5
The  difﬁculty  in  obtaining  a  diagnosis
In the 12 articles analyzed, the difﬁculty shown by patients
in dealing with waiting until completion of the diagnosis was
evident – an event hitherto regarded as a generator of anx-
iety and uncertainty. Thus, this situation is considered as a
factor that triggers emotional problems, such as depressive
reactions. Similarly, we  found in these articles the idea of a
reassuring effect at the time of presentation of the nosological
diagnosis.6–12,17,19,20,22,24
An  understanding  of  the  disease
The authors of six of the studies outlined how, after obtaining
the diagnosis, some patients could not understand the con-
stitution of the disease, even after receiving medical advice.
This experience was understood as the result of a resistance
to the diagnosis, because the act of to deny it or not to under-
stand the chronicity of the disease resulted sometimes in not
accepting the need for a longitudinal treatment. This behav-
ior was considered as being connected with nonadherence to
treatment.7,11,12,14,19,20
An  understanding  of  the  disease  by  third-parties
On the other hand, six other studies revealed the difﬁculty
of caregivers of SLE patients in understanding the disease.
These difﬁculties were related mainly to the peculiarities
of the disease, for instance, the phases of exacerbation or
remission.6,8,11,12,14,17
Temporal  change  of  the  body
Authors of 12 studies indicated the body transformation expe-
rienced by some patients as something painful, both in the
physical and emotional sense. The body transformation was
identiﬁed as stemming from the clinical symptoms (pain,
swelling, and alopecia), as well as from the treatment itself,
when, for example, the use of some medications cause ﬂuid
retention.6–14,17,21,24 0 1 5;5 5(6):522–527
The  experience  of  fatigue
The respondents, as suggested in thirteen of the studies,
described fatigue as a recurring thing, which persisted even
with the disease under control. The results of these articles
outlined negatively the fatigue experienced, by hindering rou-
tine activities, both current and old.6–12,15–17,20–24
Return  to  daily  routine
The yearning for the return of the old life routine and for the
realization of future plans was another experience pointed in
eight studies. In certain cases, as described by their authors,
there was the expectation, on the part of the patient, that the
disease would die out over time, thus allowing that these peo-
ple could conclude their interrupted life projects.6–8,10,12,22–24
Indeﬁnite  use  of  medications
Eight studies were dedicated speciﬁcally to questions about
medications. However, in the analyzed texts the experience
of using the medication was described by patients as a neg-
ative event in their lives, given the continued and indeﬁnite
use or the side effects of drugs. The use of medication was
quoted as meaning a condition of “being still sick”, even when
the patient had no symptoms of the old acute period of the
disease.6,7,10,12–14,20,22
Access  to  the  professional  support  needed
The professional support was appointed by authors of ﬁve
studies as another difﬁculty experienced by patients. Some-
times, such support was referred to as difﬁcult to access,
especially to answer questions about the disease itself. At
other times, this support was referred to as deﬁcient in under-
standing the uniqueness of each patient.6,7,13,20,21
The reviewed studies showed the uniqueness of the differ-
ent experiences of SLE patients. Together, these studies show
a conﬁguration for different experiential stages of the disease,
beginning with its emergence, extending to the diagnosis and
prognosis, through the understanding of the process of “being
sick” and by drug treatment and their evolutionary effects on
the disease. The studies also allow us to verify that patients
with SLE live in the natural expectation of improvement in
their symptoms; however, when remission occurs, there are
difﬁculties in understanding the persistence of the chronic
nature of the disease. This moment can be seen as a cure for
some patients, whereas in truth, is actually just one stage of
the disease that deserves to be better exploited (an aspect not
addressed by studies) and that the amplitude of qualitative
methods – as this study has shown – helps to outline, facili-
tating the understanding of the experiences of these patients
– in fact at all stages – as well as their handling by the patient.Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
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